Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IMPDH2 | P12268 | 1/20 | 0.43 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.43 |
| ▸ | CHUK | O15111 | 1/20 | 0.39 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.38 |
| ▸ | PKN1 | Q16512 | 1/20 | 0.37 |
| ▸ | PKN2 | Q16513 | 1/20 | 0.37 |
| ▸ | GABRP | O00591 | 1/20 | 0.37 |
| ▸ | GABRD | O14764 | 1/20 | 0.37 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.37 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.37 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.37 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.37 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.37 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.37 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.37 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.37 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.37 |
| ▸ | GABRE | P78334 | 1/20 | 0.37 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.37 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7773268 | 0.85 | PIN1 (0.45) | IMPDH2IMPDH1CHUKPIN1PKN1 | |
| SCHEMBL23348979 | 0.84 | HAO1 (0.35) | — | |
| SCHEMBL26790059 | 0.81 | HAO1 (0.36) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL26790062 | 0.75 | GABRA1 (0.36) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL6152208 | 0.74 | MAPT (0.43) | ALDH1A1 | |
| Benzotriazole SCHEMBL14975700 | 0.73 | PIK3CA (0.44) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL19640293 | 0.73 | CLK1 (0.34) | GSK3B | |
| SCHEMBL16968392 | 0.72 | ALDH1A1 (0.32) | CSNK1DCSNK1G2KDM4EALDH1A1 | |
| Water SCHEMBL7451096 | 0.72 | ALDH1A1 (0.47) | KDM4EALDH1A1GAA | |
| SCHEMBL23348984 | 0.71 | CLK1 (0.37) | GSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 95 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119461335-B | Low-temperature-resistant composite material, preparation method and application thereof in lithium ion battery anode material | 深圳市量能科技有限公司 | 2025-03-18 | — | — | CN | claimed |
| CN-119461335-A | Low-temperature-resistant composite material, preparation method and application thereof in lithium ion battery anode material | 深圳市量能科技有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-113589662-B | Composition, stripping liquid, application of stripping liquid in stripping of photoresist or photoresist residues and stripping method | 浙江奥首材料科技有限公司 | 2022-07-12 | — | — | CN | claimed |
| CN-113589662-A | Composition, stripping liquid, application of stripping liquid in stripping of photoresist or photoresist residues and stripping method | 浙江奥首材料科技有限公司 | 2021-11-02 | — | — | CN | claimed |
| EP-4665718-A1 | SMALL MOLECULES AS MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS, COMPOSITIONS AND USE THEREOF | Apogee Pharmaceuticals, Inc. (CA) | 2025-12-24 | — | — | EP | disclosed |
| US-12378231-B2 | Small molecules as monoacylglycerol lipase (MAGL) inhibitors, compositions and use thereof | APOGEE PHARMACEUTICALS, INC. (CA) | 2025-08-05 | — | — | US | disclosed |
| CN-119461335-B | Low-temperature-resistant composite material, preparation method and application thereof in lithium ion battery anode material | 深圳市量能科技有限公司 | 2025-03-18 | — | — | CN | disclosed |
| CN-119461335-B | Low-temperature-resistant composite material, preparation method and application thereof in lithium ion battery anode material | 深圳市量能科技有限公司 | 2025-03-18 | — | — | CN | disclosed |
| CN-119461335-A | Low-temperature-resistant composite material, preparation method and application thereof in lithium ion battery anode material | 深圳市量能科技有限公司 | 2025-02-18 | — | — | CN | disclosed |
| CN-119461335-A | Low-temperature-resistant composite material, preparation method and application thereof in lithium ion battery anode material | 深圳市量能科技有限公司 | 2025-02-18 | — | — | CN | disclosed |
| US-20250026742-A1 | COMPOUND AS ATR KINASE INHIBITOR | SUZHOU ARK BIOPHARMACEUTICAL CO., LTD. (CN) | 2025-01-23 | — | — | US | disclosed |
| CN-115703768-B | Compounds useful as inhibitors of ATR kinase | 苏州爱科百发生物医药技术有限公司 | 2024-12-17 | — | — | CN | disclosed |
| US-5320938-A | Occurs in the presence of iodide | EASTMAN KODAK COMPANY (US) | 1994-06-14 | — | — | US | disclosed |
| US-5288596-A | Developing with solution containing imidazole compound and benzotriazole compound | FUJI PHOTO FILM CO., LTD. (JP) | 1994-02-22 | — | — | US | disclosed |
| EP-0554000-A1 | A black-and-white silver halide photographic light-sensitive material and a method for processing the same | KONICA CORPORATION (JP) | 1993-08-04 | — | — | EP | disclosed |
| EP-0545645-A1 | Solid processing chemicals for light-sensitive halide photographic material | KONICA CORPORATION (JP) | 1993-06-09 | — | — | EP | disclosed |
| EP-0523721-A1 | Black and white direct positive image forming process | FUJI PHOTO FILM CO., LTD. (JP) | 1993-01-20 | — | — | EP | disclosed |
| US-H1020-H | Developing solution containing an antifogging agent of a benzotriazole or benzimidazole and a thioether compound | KONICA CORPORATION (JP) | 1992-02-04 | — | — | US | disclosed |
| EP-0358165-A2 | Method of developing a silver halide photographic material | KONICA CORPORATION (JP) | 1990-03-14 | — | — | EP | disclosed |
| US-4649096-A | EXPOSURE, DEVELOPMENT, ALKALI HYDROXIDE, ALKANOLAMINE, SULFITE, THIOSULFATE, P-DIHYDROXYBENZENE | MITSUBISHI PAPER MILLS, LTD. (JP) | 1987-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250026742-A1 | COMPOUND AS ATR KINASE INHIBITOR | ATR, CHEK2, CHEK1 | IMPDH2 2146/4885IMPDH1 1621/4885CHUK 228/4885 |
| US-12378231-B2 | Small molecules as monoacylglycerol lipase (MAGL) inhibitors, compositions and use thereof | MGLL, PNLIP, LPL | IMPDH2 1576/4885IMPDH1 1247/4885CHUK 2489/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.